Full-Time

Supply Chain Associate Director

Business Continuity and Resilience

Posted on 2/27/2025

Vertex Pharmaceuticals

Vertex Pharmaceuticals

1,001-5,000 employees

Develops medicines for serious diseases

Compensation Overview

$149.3k - $224k/yr

+ Bonus + Equity Awards

Senior, Expert

Company Does Not Provide H1B Sponsorship

Boston, MA, USA

Hybrid-Eligible: work remotely up to two days per week.

Category
Quality Control & Compliance
Supply Chain Management
Operations & Logistics
Required Skills
Supply Chain Management
Risk Management
Requirements
  • Strong knowledge of business continuity frameworks, standards (ISO 22301, DRII), and risk management principles.
  • Proficiency in business continuity planning tools and software (e.g. Riskonnect or similar).
  • Strong project management skills and the ability to prioritize tasks in a fast-paced environment.
  • Effective communication, leadership, and stakeholder management skills.
  • Strong analytical and problem-solving abilities to assess risk impacts and develop solutions.
  • Ability to work independently, think strategically, and drive organizational resilience.
  • Demonstrated ability to get results without authority, and execution of projects of diverse scope and complexity.
  • Exceptional presentation and communication skills.
  • Previous experience conducting business continuity tabletop exercises.
  • Bachelor’s degree in Supply Chain Management, Business, Risk Management, Emergency Management, Industrial Engineering, or a related field. Master’s degree preferred (or equivalent experience).
  • Minimum of 8-10 years in supply chain management, business continuity, risk management, or disaster recovery, preferably in the pharmaceutical industry.
  • Experience developing and leading business continuity programs across large, complex organizations.
  • Domain certification(s) such as Certified Business Continuity Professional (CBCP), Certified Supply Chain Resilience Manager (CSCRM), or similar.
Responsibilities
  • Design and implement a comprehensive business continuity framework that aligns with organizational goals and regulatory requirements.
  • Develop and maintain Business Impact Analyses (BIA) to identify critical processes, dependencies, and recovery time objectives (RTO) with support from functions’ points of contact.
  • Create, update, and document business continuity plans (BCP) for all functional areas, and supply chain disruption mitigation plans to address vulnerabilities identified across commercial programs and their respective supply chain nodes.
  • Identify potential threats, vulnerabilities, and operational risks that could disrupt business processes.
  • Collaborate with leadership and key stakeholders to develop and implement supply chain disruption mitigation strategies and plans to address vulnerabilities identified across Vertex’s commercial supply chain.
  • Monitor emerging risks (e.g., cyber threats, supply chain disruptions, geopolitical risks) that impact continuity.
  • Represents Commercial Manufacturing and Supply Chain at Mid- to Senior-Leader level forums, communicating overall risk profile and mitigations.
  • Plan and execute regular business continuity testing, including tabletop exercises, drills, and simulations.
  • Assess test results, identify gaps, and ensure corrective actions are implemented.
  • Develop training programs to educate employees on business continuity roles, responsibilities, and procedure.
  • Lead and coordinate incident response efforts during disruptions to minimize downtime and business impact.
  • Serve as a point of contact for crisis management teams, ensuring communication and escalation protocols are followed.
  • Support post-incident reviews and lessons-learned sessions to improve resilience measures.
  • Collaborate with internal teams across Commercial Manufacturing and Supply Chain (CMSC) and business partners (e.g. DTE, Corporate Risk Management & Resilience, QA, etc.) to align business continuity strategies.
  • Establishes and monitors key performance metrics for the Business Continuity processes.
  • Provide regular reports and updates to senior management on program status, risks, and improvements.
  • Monitor and evaluate the effectiveness of the business continuity program, ensuring it evolves with business changes.
  • Collaborate with key business partners on implementing improvements and opportunity areas.
  • Stay current on industry best practices, regulatory requirements, and standards (e.g., ISO 22301, NIST).
  • Implement tools and technologies to support business continuity planning and crisis management.
  • Represents CMSC on projects related to business continuity improvement initiatives.
Desired Qualifications
  • Master’s degree preferred (or equivalent experience).
  • Domain certification(s) such as Certified Business Continuity Professional (CBCP), Certified Supply Chain Resilience Manager (CSCRM), or similar.
Vertex Pharmaceuticals

Vertex Pharmaceuticals

View

Vertex Pharmaceuticals develops medicines for serious diseases, focusing on conditions like cystic fibrosis. The company conducts extensive research and development to create new drugs, often collaborating with other biotech firms to enhance its therapeutic offerings. One of its notable products is ivacaftor, which has shown effectiveness in treating cystic fibrosis. Vertex differentiates itself from competitors through its commitment to scientific innovation and strategic partnerships that expand its research capabilities. The goal of Vertex Pharmaceuticals is to improve the quality of life for patients with severe and life-threatening conditions by bringing effective treatments to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Boston, Massachusetts

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • Vertex's partnership with Orna could lead to breakthroughs in gene therapy solutions.
  • Recent investments indicate strong investor confidence in Vertex's strategic direction.
  • Vertex's reaffirmed stock rating suggests stability and potential for steady growth.

What critics are saying

  • Increased competition in cystic fibrosis treatments could impact Vertex's market share.
  • High costs of gene-editing therapies may limit their commercial success.
  • Regulatory challenges could delay approvals for Vertex's new gene-editing therapies.

What makes Vertex Pharmaceuticals unique

  • Vertex focuses on transformative medicines for serious diseases, like cystic fibrosis.
  • Partnerships with Arbor and Orna enhance Vertex's gene-editing and cell therapy capabilities.
  • Vertex's innovative R&D approach sets it apart in the biotechnology industry.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Company News

Slater Sentinel
Mar 23rd, 2025
Stevens Capital Management LP Makes New $829,000 Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Stevens Capital Management LP makes new $829,000 investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX).

Investing.com
Mar 20th, 2025
BMO maintains Vertex stock Market Perform rating and $41 target

The reaffirmation of the rating and target came after Vertex held its first analyst day since its initial public offering in 2020.

Stat News
Mar 18th, 2025
Genetics expert is first NIH director to leave under Trump

He will be replaced on an interim basis by Director Ian Smith, a former Vertex Pharmaceuticals executive.

GlobeNewswire
Mar 18th, 2025
Arbor Biotechnologies Announces $73.9 Million Series C Financing to Advance Novel Gene Editing Therapeutics

Series C led by ARCH Venture Partners and TCGX with significant participation from existing and new investors Financing extends Arbor’s cash runway into...

MarketBeat
Feb 14th, 2025
JSF Financial LLC Invests $751,000 in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

JSF Financial LLC invests $751,000 in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX).

INACTIVE